CCR5 antagonists may provide a well-tolerated switch option for patients experiencing tolerability or toxicity of their antiretroviral regimen. We analyzed stored samples from patients undergoing planned treatment interruptions for reasons other than virological failure, in order to analyze tropism evolution during fully suppressive antiretroviral therapy (ART). Two of 37 patients showed evidence of switching. Tropism switching after suppressive ART was uncommon in this cohort. Pretreatment human immunodeficiency virus (HIV) RNA tropism testing may help guide the switch to CCR5 antagonists in patients with undetectable HIV RNA.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/cid/ciq198 | DOI Listing |
Publication Analysis
Top Keywords
suppressive antiretroviral
8
antiretroviral therapy
8
ccr5 antagonists
8
hiv rna
8
patients
5
evolution coreceptor
4
tropism
4
coreceptor tropism
4
tropism hiv-infected
4
hiv-infected patients
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!